| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.0M | — |
| SG&A Expense | $1.3M | +331.6% |
| Operating Income | -$4.2M | -1061.2% |
| Net Income | -$4.2M | -1068.8% |
| EPS (Basic) | -$0.17 | -466.7% |
| EPS (Diluted) | -$0.17 | -466.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.0M | — |
| Current Assets | $11.2M | +2067.7% |
| Total Assets | $11.6M | +2135.8% |
| Current Liabilities | $137K | +840.2% |
| Total Liabilities | $361K | +2377.1% |
| Stockholders' Equity | $11.2M | +2128.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.5M | -1787.1% |
| Financing Cash Flow | $15.3M | +2329.6% |